Gonadotropin-releasing hormone analogue and recombinant human growth hormone treatment for idiopathic central precocious puberty in girls

PURPOSE: To investigate the effectiveness and safety of gonadotropin-releasing hormone analogue (GnRHa) in combination with recombinant human growth hormone (rhGH) in girls with central precocious puberty (CPP). METHODS: Clinical data of 80 girls diagnosed with idiopathic central precocious puberty...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Yuzhen, Ma, Ziyi, Yang, Xi, Ying, Yanqin, Luo, Xiaoping, Hou, Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794601/
https://www.ncbi.nlm.nih.gov/pubmed/36589818
http://dx.doi.org/10.3389/fendo.2022.1085385

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794601/
https://www.ncbi.nlm.nih.gov/pubmed/36589818
http://dx.doi.org/10.3389/fendo.2022.1085385

Ejemplares similares